BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37081723)

  • 21. [Treatment of phyllodes tumours of the breast: evaluation of 66 cases and literature review].
    Lohmeyer JA; Huster N; Lühr C; Lindner C; Wittig KS; Keck MK
    Handchir Mikrochir Plast Chir; 2021 Apr; 53(2):159-167. PubMed ID: 32785910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Wide Should Margins Be for Phyllodes Tumors of the Breast?
    Tremblay-LeMay R; Hogue JC; Provencher L; Poirier B; Poirier É; Laberge S; Diorio C; Desbiens C
    Breast J; 2017 May; 23(3):315-322. PubMed ID: 27901301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.
    Koh VCY; Thike AA; Nasir NDM; Yip GWC; Bay BH; Tan PH
    Virchows Arch; 2018 Apr; 472(4):615-621. PubMed ID: 29127495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phyllodes tumors of the breast: a retrospective analysis of 57 cases.
    Noordman PCW; Klioueva NM; Weimann MN; Borgstein PJ; Vrouenraets BC
    Breast Cancer Res Treat; 2020 Jun; 181(2):361-367. PubMed ID: 32277376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phyllodes tumors of the breast: Analysis of 35 cases from a single institution.
    Demian GA; Fayaz S; El-Sayed Eissa H; Nazmy N; Samir S; George T; El-Sherify M; Abuzalouf S
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):243-248. PubMed ID: 27406381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.
    Wei J; Tan YT; Cai YC; Yuan ZY; Yang D; Wang SS; Peng RJ; Teng XY; Liu DG; Shi YX
    Chin J Cancer; 2014 Oct; 33(10):492-500. PubMed ID: 25104281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.
    Wang F; Jia Y; Tong Z
    Jpn J Clin Oncol; 2015 Feb; 45(2):146-52. PubMed ID: 25387733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant Phyllodes Tumor of the Breast and Pregnancy: A Rare Case Report and Literature Review.
    Mustață L; Gică N; Botezatu R; Chirculescu R; Gică C; Peltecu G; Panaitescu AM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.
    Li Y; Song Y; Lang R; Shi L; Gao S; Liu H; Wang P
    Breast; 2021 Jun; 57():62-70. PubMed ID: 33774460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of phyllodes tumours for the surgeon: An algorithm.
    Ofri A; Stuart KE; Chan B; Mak C; Warrier S; Bhadri V; Mander-Jones T; O'Toole S
    Surgeon; 2022 Dec; 20(6):e355-e365. PubMed ID: 35148937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of phyllodes breast tumors.
    Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
    Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
    Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
    Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast.
    Kapiris I; Nasiri N; A'Hern R; Healy V; Gui GP
    Eur J Surg Oncol; 2001 Dec; 27(8):723-30. PubMed ID: 11735168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
    Sawalhi S; Al-Shatti M
    Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phyllodes tumor of the breast clinical experience and outcomes: A retrospective cohort tertiary hospital experience.
    Alkushi A; Arabi H; Al-Riyees L; Aldakheel AM; Al Zarah R; Alhussein F; Altamimi AM; Alsulaiman YA; Omair A
    Ann Diagn Pathol; 2021 Apr; 51():151702. PubMed ID: 33472142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of breast phyllodes tumors.
    Shin E; Koo JS
    Histol Histopathol; 2023 Aug; 38(8):865-878. PubMed ID: 36866915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phyllodes tumor of the breast.
    Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.